Carvacrol, the primary active component in oregano oil, effectively kills norovirus, a common cause of foodborne illness outbreaks in hospitals, schools and cruise ships, researchers said.
A study led by University of Arizona researcher Kelly Bright has found that carvacrol - the substance in oregano oil that gives the pizza herb its distinctive warm and aromatic smell and flavour - is effective against norovirus, causing the breakdown of the virus' tough outer coat.
Norovirus, also known as the winter vomiting disease, is the leading cause of vomiting and diarrhoea around the world.
"We have some work to do to assess its potential but carvacrol is an interesting prospect," she said.
Bright and her team - former graduate student Damian Gilling, former visiting scholar Masaaki Kitajima and current doctoral student Jason Torrey - determined whether oregano oil and carvacrol, the primary active component in oregano oil, were effective against mouse norovirus.
In the experiments, oregano oil had limited efficacy, but carvacrol resulted in a nearly 10,000-fold reduction in viral infectivity within an hour. In other words, it is 99.99 per cent effective against the virus.
Since carvacrol is a plant compound, it is generally regarded as safe for human consumption, Bright added.
This is also the first study that looks at the mechanism of breakdown in detail of a plant antimicrobial on a non-enveloped virus, Bright said.
Nonenveloped viruses like noroviruses tend to be the ones that target the gastrointestinal tract. Their tough outer protein shell - called the capsid - makes them resistant against stomach acid and allows them to travel through the gastrointestinal tract unharmed.
"Carvacrol acts directly on the virus' outer shell and breaks it down," she said.
"The virus needs that capsid to attach to the human cell, so if you break down that shell, it won't be able to cause an infection. In addition, it breaks down the virus' RNA genome. These effects are therefore likely irreversible, so the mechanism of action is an example of true virus inactivation," said Bright.
The study is published in the Journal of Applied Microbiology.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
